HSP70 drives myoblast fusion during C2C12 myogenic differentiation

• Main Authors: Savant S. Thakur, Kristy Swiderski, Victoria L. Chhen, Janine L. James, Nicki J. Cranna, A. M. Taufiqual Islam, James G. Ryall, Gordon S. Lynch
• Format: Article
• Language: English
• Published: The Company of Biologists 2020-07-01
• Series: Biology Open
• Subjects: heat shock protein 70; myogenesis; fusion; c2c12; skeletal muscle
• Online Access: http://bio.biologists.org/content/9/7/bio053918

In response to injury, skeletal muscle stem cells (MuSCs) undergo myogenesis where they become activated, proliferate rapidly, differentiate and undergo fusion to form multinucleated myotubes. Dramatic changes in cell size, shape, metabolism and motility occur during myogenesis, which cause cellular stress and alter proteostasis. The molecular chaperone heat shock protein 70 (HSP70) maintains proteostasis by regulating protein biosynthesis and folding, facilitating transport of polypeptides across intracellular membranes and preventing stress-induced protein unfolding/aggregation. Although HSP70 overexpression can exert beneficial effects in skeletal muscle diseases and enhance skeletal muscle repair after injury, its effect on myogenesis has not been investigated. Plasmid-mediated overexpression of HSP70 did not affect the rate of C2C12 proliferation or differentiation, but the median number of myonuclei per myotube and median myotube width in differentiated C2C12 myotubes were increased with HSP70 overexpression. These findings reveal that increased HSP70 expression can promote myoblast fusion, identifying a mechanism for its therapeutic potential to enhance muscle repair after injury. This article has an associated First Person interview with the first author of the paper.